Question:
Galcanezumab (Emgality)
Author: Natalia AbesadaAnswer:
Anti CGRP (cible les peptides et les empeche de se lier a son recepteur) Migraine
0 / 5 Â (0 ratings)
1 answer(s) in total
Author
Natalia Abesada
Answer:
0 / 5 Â (0 ratings)
1 answer(s) in total